Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering

Keeping Current
04/12/2025 30 min
Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering

Listen "Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering"

Descargar episodio Ver en sitio original

Episode Synopsis

Preventing the first ASCVD is critically important. In this activity, we explore the evidence for early and intensive lipid lowering to significantly reduce patient's cardiovascular (CV) risk. Credit available for this activity expires: 12/05/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/staying-ahead-first-event-evaluating-evidence-early-ldl-c-2025a1000xkj?ecd=bdc_podcast_libsyn_mscpedu

More episodes of the podcast Keeping Current

How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer? 05/12/2025
Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm 02/12/2025
Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data 27/11/2025
Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies 25/11/2025
Coexisting Comorbidities: Advancing Holistic Care in COPD 24/11/2025
Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next? 24/11/2025
Latest Advances in mHSPC: An Update From Berlin 2025 20/11/2025
Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC 20/11/2025
Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond 17/11/2025
Paving the Way for Success in Integrating Biosimilars Into Multiple Sclerosis Care: Optimizing Communication 17/11/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA